New pediatric ‘total’ care model to include
urgent/acute care, primary care and telehealth services
Mednax, Inc. (NYSE: MD), the national medical group specializing
in prenatal, neonatal and pediatric services, today announced its
affiliation with NightLight Pediatric Urgent Care (NightLight), a
private eight-clinic practice based in Houston. The affiliation
with NightLight is the first step in a new strategy to reimagine
pediatric ‘total’ care for patients in select markets throughout
the country.
There is an opportunity to fundamentally change the delivery of
pediatric care in the future. Mednax envisions a new model
comprising urgent/acute care, primary care and telehealth. Patient
services offered in the traditional pediatric urgent care clinic
will be expanded to include:
- Pediatric continuum of care, including subspecialty services
and primary care services with an integrative approach to pediatric
health
- General and developmental pediatrics for high-risk
newborns
- Complementary prenatal services with a focus on patient
education
- Wellness, behavioral health and chronic pediatric diseases
“We are extremely excited to welcome NightLight to the Mednax
family,” said James D. Swift, M.D., Chief Development Officer for
Mednax. “We believe the business that Dr. Anastasia Gentles and
Zawadi Bryant have created offers a great fit for the Pediatrix
brand as we continue our focus on women’s and children’s services.
We see an opportunity to expand and evolve the NightLight platform
to offer not just urgent care but create a broader continuum for
pediatric health and wellness.”
Founded in 2007, NightLight is a well-established practice that
cares for families in the greater Houston metro area. The practice
provides screening, diagnosis and treatment for a variety of minor
non-emergent health issues, working in partnership with community
pediatricians. Comprising seven physicians, 14 advanced practice
providers and 20 nurses and medical assistants, the group serves
more than 90,000 patients annually at eight locations throughout
Houston: Cy-Fair, Garden Oaks, Humble, Katy, Pearland, Sugar Land,
Tanglewood and Webster. As part of the affiliation, Dr. Gentles and
Ms. Bryant will take on executive roles at Mednax, leading the
development of the Company’s new pediatric 'total' care
strategy.
“For 14 years, NightLight has been guided by our mission to be a
beacon of healing that lights up lives in every community we
serve,” said Ms. Bryant. “We are excited about our next chapter as
we join the Mednax family, a leading provider of women’s and
children’s health care. Their commitment to Take great care of the
patient, every day and in every way™ resonated with our passion for
high-quality patient care. This phenomenal partnership will broaden
our reach and expand our services to families across the country,
making more nights brighter.”
This affiliation adds to the services Pediatrix provides in
Texas through its network of affiliated physicians across multiple
specialties, including maternal-fetal medicine; OB hospitalist;
neonatology; newborn nursery; newborn hearing screen; developmental
pediatrics; and pediatric cardiology, critical care, hospitalist,
infectious disease, ophthalmology, otorhinolaryngology,
orthopedics, surgery and urology. The group provides care at 30
hospital partners in the greater Houston area.
This was a cash transaction, and it is expected to be
immediately accretive to earnings. No additional terms of the
transaction were disclosed.
ABOUT MEDNAX
Mednax, Inc. is a national medical group comprised of the
nation’s leading providers of physician services. Physicians and
advanced practitioners practicing as part of Mednax are reshaping
the delivery of care within their specialties and subspecialties,
using evidence-based tools, continuous quality initiatives,
clinical research and telehealth programs to enhance patient
outcomes and provide high-quality, cost-effective care. The Company
was founded in 1979, and today, through its affiliated professional
entities, Mednax provides services through a network of more than
2,300 physicians in 39 states and Puerto Rico. Additional
information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended (the “Securities Act”),
and Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements may include, but are not limited to,
statements relating to the Company’s objectives, plans and
strategies, and all statements, other than statements of historical
facts, that address activities, events or developments that we
intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology
such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,”
“plan,” “will,” “expect,” “estimate,” “project,” “positioned,”
“strategy” and similar expressions, and are based on assumptions
and assessments made by the Company’s management in light of their
experience and their perception of historical trends, current
conditions, expected future developments and other factors they
believe to be appropriate. Any forward-looking statements in this
press release are made as of the date hereof, and the Company
undertakes no duty to update or revise any such statements, whether
as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance
and are subject to risks and uncertainties. Important factors that
could cause actual results, developments, and business decisions to
differ materially from forward-looking statements are described in
the Company’s most recent Annual Report on Form 10-K and its
Quarterly Reports on Form 10-Q, including the sections entitled
“Risk Factors”, as well the Company’s current reports on Form 8-K,
filed with the Securities and Exchange Commission, and include the
impact of the COVID-19 pandemic on the Company and its financial
condition and results of operations; the effects of economic
conditions on the Company’s business; the effects of the Affordable
Care Act and potential changes thereto or a repeal thereof; the
Company’s relationships with government-sponsored or funded
healthcare programs, including Medicare and Medicaid, and with
managed care organizations and commercial health insurance payors;
the Company’s ability to comply with the terms of its debt
financing arrangements; the impact of the divestiture of the
Company’s anesthesiology and radiology medical groups; the impact
of management transitions; the timing and contribution of future
acquisitions; the effects of share repurchases; and the effects of
the Company’s transformation initiatives, including its
reorientation on, and growth strategy for, its pediatrics and
obstetrics business.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210316005680/en/
Charles Lynch Senior Vice President, Finance and Strategy
954-384-0175 ext. 5692 charles_lynch@mednax.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Apr 2023 to Apr 2024